Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 8116 AL 8130

Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use

Schöll M, Vrillon A, Ikeuchi T, Quevenco FC, Iaccarino L, Vasileva-Metodiev SZ, Burnham SC, Hendrix J, Epelbaum S, Zetterberg H, Palmqvist S.

J Prev Alzheimers Dis. 2025 Apr;12(4):100056. doi: 10.1016/j.tjpad.2024.100056. Epub 2025 Jan 14.

The role of exosomes in diagnosis, pathophysiology, and management of Alzheimer's Disease

Daksh R, Mathew MS, Bosco AM, Sojan C, Tom AA, Bojja SL, Nampoothiri M.

Biochem Biophys Res Commun. 2025 Mar 25;754:151526. doi: 10.1016/j.bbrc.2025.151526. Epub 2025 Feb 21.

From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer's Disease Landscape

Bougea A, Debasa-Mouce M, Gulkarov S, Castro-Mosquera M, Reiss AB, Ouro A.

Medicina (Kaunas). 2025 Aug 14;61(8):1462. doi: 10.3390/medicina61081462.

Defining benefit: Clinically and biologically meaningful outcomes in the next-generation Alzheimer's disease clinical care pathway

Elhage A, Cohen S, Cummings J, van der Flier WM, Aisen P, Cho M, Bell J, Hampel H.

Alzheimers Dement. 2025 Feb;21(2):e14425. doi: 10.1002/alz.14425. Epub 2024 Dec 19.

Elevated D-dimer levels after lecanemab infusions: a case report

Zou M, Xu SS, Zhu SG, Yuan CX, Huang JF, Zhu JH, Zhang X, Wang JY.

BMC Geriatr. 2025 Sep 29;25(1):742. doi: 10.1186/s12877-025-06445-z.

Next-generation biosensor technologies for Alzheimer's disease: Innovations in diagnosis, monitoring, and treatment

Yin C, Tang X, Zeng J, Wang Z, Mi J, Liang Y, Qin D, Feng Q, Wu A.

Ageing Res Rev. 2026 Jan;114:102954. doi: 10.1016/j.arr.2025.102954. Epub 2025 Nov 19.

Randomized phase 2a trial assessing a novel septin molecular glue in Alzheimer's disease

Nuytten M, Voets M, Debroux E, Princen K, Pringels L, Fivaz M, Byl E, Ramael S, De Witte K, Boada M, Morató X, Tartari JP, Lafuente A, Macias EF, Matias-Guiu JA, Vijverberg E, Teunissen CE, Anderer P, Staggs V, Hayman V, Corbett A, Ballard C, Harrison JE, Windisch M, Westman AB, Zetterberg H, Dickson S, Mallinckrodt C, Hendrix S, Cummings J, Griffioen G.

Alzheimers Dement. 2025 Sep;21(9):e70537. doi: 10.1002/alz.70537.

SCD-plus features and AD biomarkers in cognitively unimpaired samples: A meta-analytic approach for nine cohort studies

Kuhn E, Klinger HM, Amariglio RE, Wagner M, Jessen F, Düzel E, Heneka MT, Chételat G, Rentz DM, Sperling RA, Ebenau JL, Butterbrod E, Van Der Flier WM, Sikkes SAM, Teunnissen CE, Van Harten AC, Van De Giessen EM, Rami L, Tort A, Sánchez Benavides G, Gifford KA, Van Hulle C, Buckley RF; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging Biomarkers and Lifestyle flagship study of ageing, A4 Study Team; DELCODE Study; Harvard Aging Brain Study.

Alzheimers Dement. 2025 May;21(5):e14307. doi: 10.1002/alz.14307. Epub 2025 Feb 22.

Quantum dots in neurotheranostics for the treatment of Alzheimer's disease

Sharma T, Bashir B, Sharma P, Andotra N, Singh SK, Singh TG, Vishwas S.

Ageing Res Rev. 2025 Dec;112:102876. doi: 10.1016/j.arr.2025.102876. Epub 2025 Aug 20.

Pharmacokinetic and pharmacodynamic assessment of oral nicotinamide in the NEAT clinical trial for early Alzheimer's disease

Ketron GL, Grun F, Grill JD, Feldman HH, Rissman RA, Brewer GJ.

Alzheimers Res Ther. 2025 Mar 11;17(1):59. doi: 10.1186/s13195-025-01693-y.

Acute effects of lactate infusion on metabolism, AD biomarkers, and cognition: The LEAN study

Kemna RE, Kueck PJ, Blankenship A, John CS, Johnson CN, Green ZD, Mayfield H, Yoksh L, Johnson L, Thyfault JP, Mahnken JD, Miller BF, Morris JK.

Alzheimers Dement. 2025 Dec;21(12):e70984. doi: 10.1002/alz.70984.

Associations of circulating c-reactive protein levels with central Alzheimer's disease biomarkers

Choi HJ, Byun MS, Yi D, Ahn H, Jung G, Park S, Jung JH, Keum M, Sohn BK, Kim YK, Choi H, Lee YS, Lee JY, Kang KM, Sohn CH, Huang YN, Saykin AJ, Nho K, Lee DY; KBASE Research Group.

J Prev Alzheimers Dis. 2026 Jan;13(1):100368. doi: 10.1016/j.tjpad.2025.100368. Epub 2025 Sep 17.

Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trials

Ferreira PCL, Bellaver B, Povala G, Bauer-Negrini G, Aguzzoli CS, Ferrari-Souza JP, Leffa DT, Soares C, Lussier FZ, Medeiros MS, Felix C, Ruppert E, Rohden F, Borelli WV, Karim HT, Langhough R, Christian BT, Wilson R, Hong CH, Roh HW, Patira R, Tudorascu DL, Zimmer ER, Betthauser TJ, Karikari TK, Snitz BE, Johnson SC, Son SJ, Pascoal TA.

Neurology. 2026 Jan 13;106(1):e214441. doi: 10.1212/WNL.0000000000214441. Epub 2025 Dec 9.

Advancements and challenges in using AI for biomarker detection in early Alzheimer's disease

Beheshti I, Albensi BC, Freitas A, Ghafourian T.

Drug Discov Today. 2025 Jul;30(7):104415. doi: 10.1016/j.drudis.2025.104415. Epub 2025 Jun 20.

The Diagnostic and Therapeutic Potential of Oligonucleotide Aptamers in Alzheimer's Disease

Katsipis G, Tzekaki EE, Iasonidou S, Pantazaki AA.

Cells. 2025 Sep 11;14(18):1424. doi: 10.3390/cells14181424.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias